58 related articles for article (PubMed ID: 33462161)
21. Clinical differences between elderly-onset ulcerative colitis and non-elderly-onset ulcerative colitis: A nationwide survey data in Japan.
Komoto S; Higashiyama M; Watanabe C; Suzuki Y; Watanabe M; Hibi T; Takebayashi T; Asakura K; Nishiwaki Y; Miura S; Hokari R
J Gastroenterol Hepatol; 2018 Nov; 33(11):1839-1843. PubMed ID: 29669163
[TBL] [Abstract][Full Text] [Related]
22. Relation of geriatric nutritional risk index with clinical risks in elderly-onset ulcerative colitis.
Higashiyama M; Komoto S; Suzuki Y; Watanabe M; Hibi T; Miura S; Hokari R
J Gastroenterol Hepatol; 2021 Jan; 36(1):163-170. PubMed ID: 32583472
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry.
Mak JWY; Lok Tung Ho C; Wong K; Cheng TY; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Ng SC
J Crohns Colitis; 2021 Mar; 15(3):401-408. PubMed ID: 32914171
[TBL] [Abstract][Full Text] [Related]
24. Elderly-onset vs adult-onset ulcerative colitis: a different natural history?
Zammarchi I; Lanzarotto F; Cannatelli R; Munari F; Benini F; Pozzi A; Lanzini A; Ricci C
BMC Gastroenterol; 2020 May; 20(1):147. PubMed ID: 32398011
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
Cheng D; Cushing KC; Cai T; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2021 May; 19(5):939-946.e4. PubMed ID: 32371165
[TBL] [Abstract][Full Text] [Related]
26. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
Kochar B; Cai W; Cagan A; Ananthakrishnan AN
Gastroenterology; 2020 Jun; 158(8):2104-2111.e2. PubMed ID: 32105728
[TBL] [Abstract][Full Text] [Related]
28. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
Cha JM; Park SH; Rhee KH; Hong SN; Kim YH; Seo SI; Kim KH; Jeong SK; Lee JH; Park SY; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK
Gut; 2020 Aug; 69(8):1432-1440. PubMed ID: 31822581
[TBL] [Abstract][Full Text] [Related]
29. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RW;
Intest Res; 2019 Jul; 17(3):285-310. PubMed ID: 31146509
[TBL] [Abstract][Full Text] [Related]
30. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015.
Park SH; Kim YJ; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK;
J Crohns Colitis; 2019 Oct; 13(11):1410-1417. PubMed ID: 30989166
[TBL] [Abstract][Full Text] [Related]
31. Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.
Singh S; Stitt LW; Zou G; Khanna R; Dulai PS; Sandborn WJ; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2019 May; 49(9):1188-1194. PubMed ID: 30891808
[TBL] [Abstract][Full Text] [Related]
32. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.
Coward S; Clement F; Benchimol EI; Bernstein CN; Avina-Zubieta JA; Bitton A; Carroll MW; Hazlewood G; Jacobson K; Jelinski S; Deardon R; Jones JL; Kuenzig ME; Leddin D; McBrien KA; Murthy SK; Nguyen GC; Otley AR; Panaccione R; Rezaie A; Rosenfeld G; Peña-Sánchez JN; Singh H; Targownik LE; Kaplan GG
Gastroenterology; 2019 Apr; 156(5):1345-1353.e4. PubMed ID: 30639677
[TBL] [Abstract][Full Text] [Related]
33. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
Borren NZ; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
[TBL] [Abstract][Full Text] [Related]
34. Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.
Burisch J; Katsanos KH; Christodoulou DK; Barros L; Magro F; Pedersen N; Kjeldsen J; Vegh Z; Lakatos PL; Eriksson C; Halfvarson J; Fumery M; Gower-Rousseau C; Brinar M; Cukovic-Cavka S; Nikulina I; Belousova E; Myers S; Sebastian S; Kiudelis G; Kupcinskas L; Schwartz D; Odes S; Kaimakliotis IP; Valpiani D; D'Incà R; Salupere R; Chetcuti Zammit S; Ellul P; Duricova D; Bortlik M; Goldis A; Kievit HAL; Toca A; Turcan S; Midjord J; Nielsen KR; Andersen KW; Andersen V; Misra R; Arebi N; Oksanen P; Collin P; de Castro L; Hernandez V; Langholz E; Munkholm P;
J Crohns Colitis; 2019 Feb; 13(2):198-208. PubMed ID: 30289522
[TBL] [Abstract][Full Text] [Related]
35. Ethnoracial, Geographic, and Socioeconomic Disparities and Variations in Inflammatory Bowel Disease.
Fung BM; Perrault J; Tabibian JH
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1176-1177. PubMed ID: 29535055
[No Abstract] [Full Text] [Related]
36. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
Mañosa M; Calafat M; de Francisco R; García C; Casanova MJ; Huelín P; Calvo M; Tosca J; Fernández-Salazar L; Arajol C; Zabana Y; Bastida G; Hinojosa J; Márquez L; Barreiro-de-Acosta M; Calvet X; Monfort D; Gómez-Garcia MR; Rodríguez E; Huguet JM; Rojas-Feria M; Hervias D; Atienza R; Busquets D; Zapata E; Dueñas C; Charro M; Martínez-Cerezo FJ; Plaza R; Vázquez JM; Gisbert JP; Cañete F; Cabré E; Domènech E;
Aliment Pharmacol Ther; 2018 Mar; 47(5):605-614. PubMed ID: 29369387
[TBL] [Abstract][Full Text] [Related]
37. Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.
Lewis JD; Scott FI; Brensinger CM; Roy JA; Osterman MT; Mamtani R; Bewtra M; Chen L; Yun H; Xie F; Curtis JR
Am J Gastroenterol; 2018 Mar; 113(3):405-417. PubMed ID: 29336432
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease.
Aniwan S; Park SH; Loftus EV
Gastroenterol Clin North Am; 2017 Sep; 46(3):463-480. PubMed ID: 28838409
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and long-term prognosis of elderly onset ulcerative colitis.
Song EM; Lee HS; Park SH; Kim GU; Seo M; Hwang SW; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
J Gastroenterol Hepatol; 2018 Jan; 33(1):172-179. PubMed ID: 28543366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
